R&B 2026 outlook raised to mid-to-high single digit growth
WTW reported strong Q4 results with 6% organic growth and 13% adjusted EPS growth ex-Transact, guiding to continued mid-single-digit growth and margin expansion in 2026. The call emphasized the success of its talent and specialization strategy, highlighted by wins in construction, M&A, and digital infrastructure. Management provided positive guidance for 2026, noting strength in health and CRB while managing headwinds in BDO and ICT. WTW delivered 6% organic growth in Q4 2025 and 5% for the full year, with strong performance in Corporate Risk & Broking (8% growth) driven by M&A and specialty lines.
Buzzberg 분석R&B 2026 outlook raised to mid-to-high single digit growthWTW reported strong Q4 results with 6% organic growth and 13% adjusted EPS growth ex-Transact, guiding to continued mid-single-digit growth and margin expansion in 2026. The call emphasized the success of its talent and specialization strategy, highlighted by wins in construction, M&A, and digital infrastructure. Management provided positive guidance for 2026, noting strength in health and CRB while managing headwinds in BDO and ICT. WTW delivered 6% organic growth in Q4 2025 and 5% for the full year, with strong performance in Corporate Risk & Broking (8% growth) driven by M&A and specialty lines.전체 분석 보기분석 접기
WTW reported strong Q4 results with 6% organic growth and 13% adjusted EPS growth ex-Transact, guiding to continued mid-single-digit growth and margin expansion in 2026. The call emphasized the success of its talent and specialization strategy, highlighted by wins in construction, M&A, and digital infrastructure. Management provided positive guidance for 2026, noting strength in health and CRB while managing headwinds in BDO and ICT. WTW delivered 6% organic growth in Q4 2025 and 5% for the full year, with strong performance in Corporate Risk & Broking (8% growth) driven by M&A and specialty lines.
Management expects high single-digit growth in the health business for 2026, driven by projected 10%+ global healthcare inflation and strong demand.
The company is projecting mid-to-high single-digit CRB growth and mid-to-high single-digit R&B growth in 2026, despite expectations of continued rate softening for clients.
Completed the Newfront acquisition and announced plans to acquire Cushion and Flowstone Partners, focusing on technology-led growth and portfolio optimization.
BDO rev growth5%
reported
CAREER rev growth10%
reported
CRB rev growth8%
reported
HEALTH rev growth4%
reported
이번 분기에 달라진 점
01
Guidance
R&B 2026 outlook raised to mid-to-high single digit growth
Guidance tone
02
Guidance
Health segment expects high single-digit growth in 2026
Guidance tone
03
Guidance
Career growth expected mid-single-digit in 2026
Guidance tone
04
Guidance
BD&O growth guided low single-digit in 2026 due to Medicare changes
Guidance tone
AI, 자본지출 및 수요 분석
AI
플랫폼 및 수익화
Management highlighted WeDo, its AI and automation platform, as a critical driver of margin expansion and efficiency in 2025, with continued benefits expected as they scale automation and embed capabilities. They are also partnering with leading agentic AI innovators to explore high-impact use cases, and Newfront's proprietary digital and AI-driven platform is seen as complementary.
수요
수주 및 전환
Management expresses confidence in 2026, guided by momentum from 2025, a strong pipeline, and portfolio optimization through acquisitions, despite acknowledging pricing headwinds in the broking business.
톤 · Confident
Management repeatedly expressed confidence in momentum, strategic execution, and the ability to deliver on 2026 goals, citing strong organic growth, new business wins, and disciplined portfolio optimization.
공급망 알파
A1
WTW is seeing high healthcare inflation globally, projecting a global average of over 10% for 2026, which is driving demand for their consulting and brokerage services.
“We can get high healthcare inflation basically everywhere around the world, and it's projected to continue. We're projecting a global average of over 10% for 2026.”
WTW has an expectation of continued 'rate softening across various lines' in the commercial insurance market, which would pressure premium growth for insurers but can be a tailwind for brokers focused on new business volume.
WTW has an expectation of continued 'rate softening across various lines' in the commercial insurance market, which would pressure premium growth for insurers but can be a tailwind for brokers focused on new business volume. — Sustained rate softening, as described by a major broker, could impact underwriting profitability and premium growth for property & casualty insurers, potentially leading to a more competitive market.
… was 8% for the full year. This was on top of the 9% growth rate CRB achieved in the prior year. CRB's growth this quarter was primarily driven by our global specialization strategy, which continued to support new business wins and client renewals despite more challenging rate environments. We recorded significant new business activity across all regions this quarter with notable contributions from construction, surety, marine and credit risk solutions. As expected, we continue to see a challenging growth environment with rate softening across various lines. Nonetheless, our specialization strategy is resonating in the market and we are pleased by the results. We continue to expect mid to high single digit growth in CRB for 2026. In our insurance consulting and technology business, revenue declined 1% versus last year's fourth quarter when ICT delivered 11% growth. Full year growth was 1% compared to 4% last year. Our combined approach of consulting and technology continues to add value. However, the trends we've highlighted in the last three quarters still persist with continued weakness as expected in the consulting environment and clients remaining cautious about making large …
WTW is seeing high healthcare inflation globally, projecting a global average of over 10% for 2026, which is driving demand for their consulting and brokerage services.
Hey, good morning. Within health, you did 6% organic for the full year, and you're talking about high single-digit next year. Can we kind of break apart how much you're expecting to come from health care inflation versus new business wins or improving retention?
Yep, just to pick up on your point about new business and strong client retention, we grew our market share for global benefits management. We had a very high win rate in the middle market with some recently enhanced solutions for that market segment. We expanded work for existing clients with new specialty solutions and additional forecasting and analytical work. And then to build on some of the comments about the external environment, we can get high healthcare inflation basically everywhere around the world, and it's projected to continue. We're projecting a global average of over 10% for 2026. And as I mentioned on our call last quarter, we don't expect that to drop quickly because of the high cost of new technology, new prescription drugs, gene therapies, plus the fact that people are using healthcare systems a lot more. So that means planning for managing those cost increases is a top priority for employers virtually everywhere. And we are very well positioned to help with that given our core consulting and brokerage offerings. We've also introduced new solutions like an RX direct access offering to their employees. So for 2026, we're expecting more of what we saw in 2025. Commission increases, more revenue with existing clients, new client appointments, and that makes us confident in delivering high single-digit growth for 2026.
🍪 쿠키
당사는 이 사이트 운영 및 분석을 위해 쿠키를 사용합니다. 거부해도 콘텐츠 접근에는 영향을 미치지 않습니다.